← All trials
NCT04635241
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2020
- Primary completion
- Apr 1, 2021
- Completion date
- Jun 1, 2021
- First posted
- Nov 19, 2020
- Last posted
- Dec 16, 2020
- Enrollment
- 712
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Australian National UniversityLead sponsor
- Helwan UniversityCollaborator
- Australian National UniversityStudy chair
- Australian National UniversityReponsible party - principal investigator
- Clinica San Camilo, ArgentinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.